Porphyromonas gingivalis 引起的血源性扩散性严重肺炎:一个病例报告
Zhou Yuanjun1, Cai Yan1, Zhang Qingyan1
1Department of Intensive Care Medicine, Zhenjiang First People's Hospital, Zhenjiang City, Jiangsu Province, China.
The Journal of international medical research
|March 14, 2024
概括
Porphyromonas gingivalis 是一种常见的口腔细菌,可以通过在口腔卫生不良和糖尿病患者的血流入侵引起严重的肺炎. 这一案例凸显了牙周病与全身感染之间的关键联系.
科学领域:
- 口腔微生物学 口腔微生物学
- 传染性疾病 传染性疾病
- 临界护理医学 临界护理医学
背景情况:
- Porphyromonas gingivalis 是牙周炎的一个关键病原体,通常会导致口腔感染.
- 由P. gingivalis传播的感染很少见,对其系统性影响的理解有限.
研究的目的:
- 报告一种罕见的严重肺炎病例,由P. gingivalis血流入侵引起.
- 强调牙周病与免疫受损患者严重的全身感染之间的潜在联系.
主要方法:
- 一个患有糖尿病和牙周炎的患者的病例报告.
- 诊断通过下一代膜洗液和血液样本的测序来确认.
- 治疗涉及有针对性的抗微生物疗法.
主要成果:
- P. gingivalis 细菌病导致了血源性扩散性严重肺炎.
- 随着适当的抗菌药物治疗和呼吸系统支持,患者的病情有所改善.
- 从机械通风中成功恢复和断奶已经实现.
结论:
- 牙周病可能是严重的全身感染的来源,包括肺炎.
- 早期识别和有针对性的治疗对于管理P. gingivalis引起的肺炎至关重要.
- 重症护理临床医生应考虑严重肺炎患者的口腔健康状况,特别是那些患有糖尿病等风险因素的患者.
相关概念视频
01:30Pneumonia I: Introduction
233
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
233
01:29Pneumonia II: Pathophysiology
268
The pathophysiology of pneumonia involves the following steps:
268
01:30Pneumonia III: Complications and Assessment
208
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
208
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324